Keros Therapeutics Inc (KROS)
Keros Announces Return of $375 Million in Excess Capital to Stockholders
Merck & Company Inc (MRK)
Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia
Integra LifeSciences Holdings (IART)
New Form 8-K - INTEGRA LIFESCIENCES HOLDINGS CORP Filed: 2025-06-09 AccNo: 0000917520-25-000060 Size: 353 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Lipocine Inc. (LPCN)
Dr. Reddy’s Laboratories Ltd (RDY)
Cara Therapeutics (CARA)
Hoth Therapeutics Inc (HOTH)
RenovoRx Inc. (RNXT)
Aytu BioPharma Inc. (AYTU)
Portage Biotech Inc. (PRTG)
Portage Biotech and Compedica Stock-for-Stock Exchange
Alnylam Pharmaceuticals Inc (ALNY)
Alnylam Receives European Commission Approval forAMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy